Insulet | PODD - Trade Debtors

Stock Price
182.87
Daily Change
-5.44 -2.89%
Monthly
-12.09%
Yearly
-27.22%
Q2 Forecast
185.50

Insulet reported $516.9M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
Align Technology USD 1.1B 2.38M Dec/2025
AtriCure USD 66.65M 3.67M Dec/2025
Avanos Medical USD 103.8M 7.7M Dec/2025
Baxter International USD 2.01B 231M Dec/2025
Becton, Dickinson and Co. USD 2.51B 486M Dec/2025
Boston Scientific USD 2.93B 98M Dec/2025
Cardinal Health USD 13.66B 108M Dec/2025
Cooper Companies USD 807.1M 21.9M Dec/2025
Dexcom USD 1.28B 167.3M Dec/2025
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Globus Medical USD 743.66M 55.54M Dec/2025
ICU Medical USD 180.52M 11.03M Dec/2025
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 516.9M 54.7M Dec/2025
Integra LifeSciences USD 278.85M 16.69M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Masimo USD 391.9M 36M Dec/2025
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 223.61M 7.9M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Solventum Corp USD 1.18B 8M Dec/2025
Stryker USD 4.04B 396M Dec/2025
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 345.58M 247.07M Dec/2025
West Pharmaceutical Services USD 685.6M 111.2M Mar/2026
Zimmer Biomet Holdings USD 1.7B 106.1M Dec/2025